Form 10-K/A BioRestorative Therapies For: Dec 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St hits two-week lows as rising bond yields, Walmart results drag
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Roth/MKM Reiterates Buy Rating on BioRestorative Therapies Inc. (BRTX)
June 12, 2024 2:48 PM EDTRoth/MKM analyst Jonathan Aschoff reiterated a Buy rating and $15.00 price target on BioRestorative Therapies Inc. (NASDAQ: BRTX)
The analyst comments "BRTX ended 1Q24 with $16.4M in cash. In February, BRTX released encouraging, preliminary, blinded Phase 2 results with BRTX-100 in the first four cLDD... More
